Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
60 Degrees Pharmaceuticals Inc. Warrant (NASDAQ : SXTPW) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Its lead product, ARAKODA (tafenoquine), is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older. The Company's pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases; new products that contain the Arakoda regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. The ARAKODA regimen of tafenoquine is in Phase II study data in patients with mild-moderate COVID-19 disease. It is also planning a clinical study to assess the utility of ARAKODA as a treatment for human babesiosis. The Company is also developing Celgosivir for the treatment of COVID-19, respiratory syncytial virus (RSV), and dengue.
Quote
| Last: | $0.0386 |
|---|---|
| Change Percent: | -1.03% |
| Open: | $0.0389 |
| Close: | $0.039 |
| High: | $0.0389 |
| Low: | $0.0386 |
| Volume: | 4,455 |
| Last Trade Date Time: | 06/10/2026 10:25:40 am |
Stock Data
| Market Cap: | $4,346,785 |
|---|---|
| Float: | 1,039,738 |
| Insiders Ownership: | N/A |
| Institutions: | 1 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.60degreespharma.com |
| Country: | US |
| City: | Washington |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about 60 Degrees Pharmaceuticals Inc. Warrant (NASDAQ: SXTPW).
